Research News and Research

RSS

Laxai Pharma purchases OSR Solutions CRO for $3.6M

Laxai Pharma, Ltd. today announced that it has completed its first acquisition in the clinical research services space by purchasing all of the assets of OSR Solutions, Inc., a New Jersey based contract research organization, for $3.6 million consisting of the following: $1.5mm in cash, $0.75mm in notes, $0.60mm in assumed liabilities, and 5.6mm common shares of Laxai Pharma, Ltd. -- about 10% of the issued and outstanding common shares at closing. The acquisition was financed by a combination of debt and equity.

12 Mar 2010

KHN column -- Public reverse mortgages and long-term care: Can they work together?

In his latest Kaiser Health News column, Howard Gleckman writes: "Here's the problem: By the time we need long-term care services we often don't have readily available resources to pay for them.

12 Mar 2010

Democrats close to health bill deal as some Democrats - and all Republicans - hold out

Congressional Democrats, reportedly closing in on a final health reform agreement, are seeking to alleviate concerns of reluctant members.

12 Mar 2010

Hamilton Health Sciences establishes new research facility

Hamilton's role as one of the world's leading centres in cardiac, vascular and stroke research was amplified today with the grand opening of the David Braley Cardiac, Vascular and Stroke Research Institute at the Hamilton General Hospital site of Hamilton Health Sciences.

12 Mar 2010

Senate passes extension of COBRA, other unemployment benefits

The Senate passed a $140 billion "jobs bill" Wednesday that will extend unemployment coverage, increase federal Medicaid funding, block cuts to physician pay and preserve numerous tax breaks and credits that would have expired without congressional action, The Christian Science Monitor reports. "Jobs trump the national debt. That's the message from a robust, bipartisan Senate vote…" (Chaddock, 3/10).

12 Mar 2010

PhRMA spends $6.3 million lobbying in fourth quarter, slight increase from year before

The Pharmaceutical Research and Manufacturers of America spent $6.3 million lobbying Congress and other government arms on health care in the fourth quarter of 2009, The Associated Press reports. PhRMA "spent just 2 percent more than the $6.17 million it paid out for lobbying in the year-ago period.

12 Mar 2010

TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for breast cancer study

Many women live with breast cancer that does not respond to standard medical treatment, a condition that researchers at the Virginia G. Piper Cancer Center at Scottsdale Healthcare want to change by aggressively targeting specific genes.

12 Mar 2010

Traumatic brain injuries may lead to life-threatening complications

One of the most common questions I am asked after someone hits their head is, "How serious is this bump on my head and should I make an appointment?" Head injuries are the result of trauma to the scalp, skull or brain. Concussion, the most common type of traumatic brain injury (TBI), is an injury that occurs after a blow to the head and results in a temporary loss of consciousness.

12 Mar 2010

Does Medicare 'doughnut hole' spur increase in foreign drug imports?

Medill Reports: "Unless federal legislation closes the Medicare coverage gap colloquially known as the 'doughnut hole,' seniors may opt for online drug imports to alleviate steep prescription costs. ... 'As seniors start falling into the doughnut hole, they are going online to find deals on prescription drugs, whether they're based in the U.S. or in other countries,' said Gabriel Levitt, vice president of PharmacyChecker.com LLC, a leader in the evaluation of online and mail-order pharmacies in both the U.S. and abroad.

12 Mar 2010

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

Baxter International Inc., in conjunction with DynPort Vaccine Company LLC, a CSC Company, today presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter’s Vero cell culture platform and does not contain an adjuvant or preservatives. The data were presented at the International Congress on Infectious Disease (ICID) in Miami, Florida.

From Baxter International Inc. 12 Mar 2010

Sebelius attacks health insurers, they fight back

Health and Human Services Secretary Kathleen Sebelius "pleaded with insurance companies on Wednesday to scrap their campaign against President Obama's health care bill and to work with the White House to pass it," The New York Times reports.

12 Mar 2010

Powerful Catholic quietly shaping abortion, health bill debate

Kaiser Health News reports on Richard Doerflinger, who doesn't look the part of a high-powered political strategist. Bearded and bespectacled, he works in a small, cluttered office out of one of Washington's less fashionable neighborhoods, far from the lobbying bastions of K Street.

12 Mar 2010

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer.

12 Mar 2010

Hospitals cope with losing money

Kentucky's Jewish Hospital and St. Mary's HealthCare is eliminating 500 jobs this month. The layoffs represent the first large-scale cuts in a Louisville-area hospital system since the recession began.

12 Mar 2010

Study questions frequency of heart angiograms

A recent study raises questions about the frequency of doctors' use of elective heart angiograms, which showed no disease in almost 40 percent of patients. BusinessWeek reports: "Doctors may be sending patients too quickly for elective angiograms to detect heart disease, exposing them to radiation and driving up U.S. health-care costs, a study suggests.

12 Mar 2010

Covidien to use FDA, Health Canada approved Mo 99 from Maria for manufacturing Tc 99m generators

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) and Health Canada have approved the use of the Maria Research Reactor (Maria) in Poland as a site to irradiate highly-enriched uranium targets for Molybdenum 99 (Mo 99) production. Covidien will use the Mo 99 obtained from Maria in the manufacture of its Technetium 99m (Tc 99m) generators. Patients should begin to benefit from Maria-produced Mo 99 in the United States and Canada later this month.

12 Mar 2010

PSA test is still the best option for diagnosing prostate cancer

When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story.

12 Mar 2010

Congress, Obama continue health reform push

"Health care reform takes center stage Thursday as President Obama and top congressional Democrats work behind closed doors to nail down a final agreement," CNN reports. House Speaker Nancy Pelosi, D-Calif., hosted a "meeting of the entire House Democratic caucus in the morning," while Senate Majority Leader Harry Reid plans to hold a news conference that will "build public momentum by framing the issue in more personal terms."

12 Mar 2010

Obama makes impassioned argument for health reform, tough measures to combat health fraud

A shirt-sleeved President Barack Obama took his closing arguments for health care reform to the St. Louis area Wednesday.

12 Mar 2010

Microchip Biotechnologies renamed as IntegenX

Microchip Biotechnologies, a maker of automated microscale biotech laboratory systems, today announced that it has changed its business name to IntegenX. The new name articulates the company's focus on integrating sample preparation and analysis technologies into complete products that address generic problems shared by life science and biotechnology research laboratories worldwide.

12 Mar 2010

Research News and Research

Laxai Pharma purchases OSR Solutions CRO for $3.6M

KHN column -- Public reverse mortgages and long-term care: Can they work together?

Democrats close to health bill deal as some Democrats - and all Republicans - hold out

Hamilton Health Sciences establishes new research facility

Senate passes extension of COBRA, other unemployment benefits

PhRMA spends $6.3 million lobbying in fourth quarter, slight increase from year before

TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for breast cancer study

Traumatic brain injuries may lead to life-threatening complications

Does Medicare 'doughnut hole' spur increase in foreign drug imports?

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

Sebelius attacks health insurers, they fight back

Powerful Catholic quietly shaping abortion, health bill debate

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

Hospitals cope with losing money

Study questions frequency of heart angiograms

Covidien to use FDA, Health Canada approved Mo 99 from Maria for manufacturing Tc 99m generators

PSA test is still the best option for diagnosing prostate cancer

Congress, Obama continue health reform push

Obama makes impassioned argument for health reform, tough measures to combat health fraud

Microchip Biotechnologies renamed as IntegenX

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence